Receptor editing is impaired in lupus-prone MRL/lpr mice

被引：0
|
作者：
Feeney, Ann J. [1 ]
Lamoureux, Jennifer [1 ]
Nemazee, David [1 ]
Watson, Lisa [1 ]
机构：
[1] Scripps Res Inst, La Jolla, CA 92037 USA
来源：
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [1] Therapeutic Effects of Triptolide on Lupus-prone MRL/lpr Mice
    Huang, Xueqin
    Wen, Chengping
    Wei, Hua
    [J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (05) : 681 - 688
  • [2] Fate of immune deposits in lupus-prone MRL/Mp lpr/lpr mice
    Cruse, JM
    Lewis, RE
    Dilioglou, S
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1208 - A1208
  • [3] Reduced receptor editing in lupus-prone MRL/1pr mice
    Lamoureux, Jennifer L.
    Watson, Lisa C.
    Cherrier, Marie
    Skog, Patrick
    Nemazee, David
    Feeney, Ann J.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (12): : 2853 - 2864
  • [4] Depression is an early disease manifestation in lupus-prone MRL/lpr mice
    Gao, Hua-Xin
    Campbell, Sean R.
    Cui, Min-Hui
    Zong, Pu
    Hee-Hwang, Jong
    Gulinello, Maria
    Putterman, Chaim
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2009, 207 (1-2) : 45 - 56
  • [5] Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice
    Matsumoto, K
    Watanabe, N
    Akikusa, B
    Kurasawa, K
    Matsumura, R
    Saito, Y
    Iwamoto, I
    Saito, T
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 486 - 494
  • [6] Treatment of Lupus-prone MRL-lpr Mice with the Mitochondrial Antioxidant MitoQ
    Budd, Ralph
    Fortner, Karen
    Blanco, Luz
    Kaplan, Mariana
    Perl, Andras
    Busliewicz, Iwona
    MacPherson, Greg
    Murphy, Mike
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [7] Mitochondrial Dysfunction in the Liver of Lupus-Prone MRL/Lpr Mice Prior to Disease Onset
    Oaks, Zachary A.
    Telarico, Tiffany
    Perl, Andras
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S624 - S625
  • [8] Nucleolin as the earliest target molecule of autoantibodies produced in MRL/lpr lupus-prone mice
    Hirata, D
    Iwamoto, M
    Yoshio, T
    Okazaki, H
    Masuyama, J
    Mimori, A
    Minota, S
    [J]. CLINICAL IMMUNOLOGY, 2000, 97 (01) : 50 - 58
  • [9] Therapeutic effect of dihydroartemisinin on lupus-prone MRL/lpr mice and its mechanism of action
    Jiang, A'pei
    Pan, Jieli
    Jiang, Fusheng
    Li, Meiya
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 9839 - 9844
  • [10] The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
    Shi, Yu
    Yao, Wen
    Sun, Li
    Li, Guomin
    Liu, Haimei
    Ding, Peipei
    Hu, Weiguo
    Xu, Hong
    [J]. BMC NEPHROLOGY, 2019, 20 (01)
12345